Analyst Price Targets — EMBC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 13, 2026 2:37 pm | — | Mizuho Securities | $12.00 | $9.02 | TheFly | Embecta price target lowered to $12 from $14 at Mizuho |
| May 23, 2025 11:21 am | Marie Thibault | BTIG | $25.00 | $10.72 | TheFly | Embecta price target lowered to $25 from $26 at BTIG |
| December 2, 2024 11:18 am | Kallum Titchmarsh | Morgan Stanley | $20.00 | $20.68 | StreetInsider | Morgan Stanley Upgrades Embecta (EMBC) to Overweight |
| November 27, 2024 11:05 am | Marie Thibault | BTIG | $26.00 | $19.80 | StreetInsider | BTIG Upgrades Embecta (EMBC) to Buy |
| July 15, 2024 8:03 am | Kallum Titchmarsh | Morgan Stanley | $12.00 | $13.17 | TheFly | Embecta price target lowered to $12 from $16 at Morgan Stanley |
| August 16, 2022 7:51 am | — | Morgan Stanley | $36.00 | $33.42 | Benzinga | Morgan Stanley Maintains Equal-Weight on Embecta, Raises Price Target to $36 |
Latest News for EMBC
The S&P 600 Small Cap index offers exposure to quality small-cap stocks with earnings requirements, providing growth potential and less analyst coverage. Eight S&P 600 small-cap dividend stocks meet the 'IDEAL' criteria: dividends from $1K invested exceed share price and free cash flow supports payouts. Top ten S&P 600 small-cap dividend dogs are projected to deliver an average 64.97% net gain by April 2027, with…
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
This strategic move aims to enhance Embecta's capabilities in drug-delivery systems.
Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based medical supplies company Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based…
Pacific Health Care Organization (OTCMKTS:PFHO - Get Free Report) and Embecta (NASDAQ: EMBC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability. Analyst Ratings This is a summary
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.